Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- $13.7 B annual GDP loss due to climate-induced mental health issues: Report
- Funding is key to make cooperatives self-sustainable, potential to create up to 5.5 cr jobs by 2030: a report by Primus Partners
- The Digital Personal Data Protection (DPDP) Act of 2023
- Bajaj Auto gears up to reclaim top spot with game-changing CNG-powered entry-level bike